Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myxovirus Infection”

17 trials

Showing 17 of 17 results

Testing effectiveness (Phase 2)Study completedNCT00258934
What this trial is testing

Immunogenicity Study of the Influenza Vaccine in Adults

Who this might be right for
Orthomyxoviridae InfectionsInfluenza
Sanofi Pasteur, a Sanofi Company 978
Large-scale testing (Phase 3)Study completedNCT00383526
What this trial is testing

Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 3,707
Not applicableStudy completedNCT02018198
What this trial is testing

FebriDx DISRUPT Acute Respiratory Infection Trial in Acute Respiratory Infection: An Evaluation of FebriDx® POC Test

Who this might be right for
Acute Respiratory Tract Infections
Rapid Pathogen Screening 540
Not applicableStudy completedNCT06746259
What this trial is testing

FebriDx® Method Comparison Study Protocol

Who this might be right for
Acute Respiratory Infections (ARIs)
Lumos Diagnostics 800
Large-scale testing (Phase 3)Study completedNCT00391053
What this trial is testing

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 3,851
Not applicableStudy completedNCT06668025
What this trial is testing

MxA-Guided Antiviral Treatment in Respiratory Viral Infections

Who this might be right for
Respiratory Viral InfectionsInfluenzaSARS CoV-2
Capital Medical University 86
Testing effectiveness (Phase 2)Study completedNCT00703651
What this trial is testing

Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults

Who this might be right for
InfluenzaOrthomyxoviridae InfectionMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 1,150
Large-scale testing (Phase 3)Study completedNCT00772109
What this trial is testing

Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 4,292
Testing effectiveness (Phase 2)Study completedNCT00551031
What this trial is testing

Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects

Who this might be right for
InfluenzaMyxovirus Infection
Sanofi 2,098
Testing effectiveness (Phase 2)Study completedNCT00845429
What this trial is testing

Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects

Who this might be right for
InfluenzaOrthomyxovirusesMyxovirus Infection
Sanofi 729
Testing effectiveness (Phase 2)Study completedNCT00388583
What this trial is testing

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi 817
Large-scale testing (Phase 3)Study completedNCT00383539
What this trial is testing

Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 2,256
Testing effectiveness (Phase 2)Study completedNCT00775450
What this trial is testing

Influenza Vaccine Revaccination in Ambulatory Elderly Subjects

Who this might be right for
InfluenzaOrthomyxovirus InfectionMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 807
Testing effectiveness (Phase 2)Study completedNCT00776438
What this trial is testing

Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines

Who this might be right for
InfluenzaOrthomyxovirus InfectionsMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 160
Testing effectiveness (Phase 2)Study completedNCT00296829
What this trial is testing

Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 1,080
Not applicableLooking for participantsNCT07211997
What this trial is testing

FebriDx® Pediatric Validation Study

Who this might be right for
Acute Respiratory Infections (ARIs)
Lumos Diagnostics 800
Testing effectiveness (Phase 2)Study completedNCT00391391
What this trial is testing

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi 520

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation